Coronavirus vaccine: Moderna seeks US, Europe authorisation

US firm Moderna said it would file requests for emergency authorisation of its Covid-19 vaccine in the United States and Europe on Monday, after full results confirmed a high efficacy estimated at 94.1 per cent.“We believe that our vaccine will provide a new and powerful tool that may change the course of this pandemic and help prevent severe disease, hospitalisation and death,” said the company’s CEO Stephane Bancel.If the US Food and Drug Administration agrees it is safe and effective, the…

Read the original article at South China Morning Post